These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22844983)

  • 1. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
    Schmitt J; Spuls P; Boers M; Thomas K; Chalmers J; Roekevisch E; Schram M; Allsopp R; Aoki V; Apfelbacher C; Bruijnzeel-Koomen C; Bruin-Weller M; Charman C; Cohen A; Dohil M; Flohr C; Furue M; Gieler U; Hooft L; Humphreys R; Ishii HA; Katayama I; Kouwenhoven W; Langan S; Lewis-Jones S; Merhand S; Murota H; Murrell DF; Nankervis H; Ohya Y; Oranje A; Otsuka H; Paul C; Rosenbluth Y; Saeki H; Schuttelaar ML; Stalder JF; Svensson A; Takaoka R; Wahlgren CF; Weidinger S; Wollenberg A; Williams H
    Allergy; 2012 Sep; 67(9):1111-7. PubMed ID: 22844983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
    Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
    J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.
    Jacobson ME; Thomas KS; Apfelbacher CJ; Leshem YA; Williams HC; Gerbens LAA; Spuls PI; Schmitt J; Howells L; Katoh N; Simpson EL;
    Arch Dermatol Res; 2023 Nov; 315(9):2617-2622. PubMed ID: 37432466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.
    Chalmers J; Deckert S; Schmitt J;
    Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):227-33. PubMed ID: 26153875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
    Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
    Leshem YA; Chalmers JR; Apfelbacher C; Furue M; Gerbens LAA; Prinsen CAC; Schmitt J; Spuls PI; Thomas KS; Williams HC; Simpson EL;
    J Am Acad Dermatol; 2020 May; 82(5):1181-1186. PubMed ID: 31926221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Chalmers JR; Thomas KS; Apfelbacher C; Williams HC; Prinsen CA; Spuls PI; Simpson E; Gerbens LAA; Boers M; Barbarot S; Stalder JF; Abuabara K; Aoki V; Ardeleanu M; Armstrong J; Bang B; Berents TL; Burton T; Butler L; Chubachi T; Cresswell-Melville A; DeLozier A; Eckert L; Eichenfield L; Flohr C; Futamura M; Gadkari A; Gjerde ES; van Halewijn KF; Hawkes C; Howells L; Howie L; Humphreys R; Ishii HA; Kataoka Y; Katayama I; Kouwenhoven W; Langan SM; Leshem YA; Merhand S; Mina-Osorio P; Murota H; Nakahara T; Nunes FP; Nygaard U; Nygårdas M; Ohya Y; Ono E; Rehbinder E; Rogers NK; Romeijn GLE; Schuttelaar MLA; Sears AV; Simpson MA; Singh JA; Srour J; Stuart B; Svensson Å; Talmo G; Talmo H; Teixeira HD; Thyssen JP; Todd G; Torchet F; Volke A; von Kobyletzki L; Weisshaar E; Wollenberg A; Zaniboni M
    Br J Dermatol; 2018 May; 178(5):e332-e341. PubMed ID: 29672835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HOME Core outcome set for clinical trials of atopic dermatitis.
    Williams HC; Schmitt J; Thomas KS; Spuls PI; Simpson EL; Apfelbacher CJ; Chalmers JR; Furue M; Katoh N; Gerbens LAA; Leshem YA; Howells L; Singh JA; Boers M;
    J Allergy Clin Immunol; 2022 Jun; 149(6):1899-1911. PubMed ID: 35351441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
    Leshem YA; Chalmers JR; Apfelbacher C; Katoh N; Gerbens LAA; Schmitt J; Spuls PI; Thomas KS; Howells L; Williams HC; Simpson EL;
    JAMA Dermatol; 2022 Dec; 158(12):1429-1435. PubMed ID: 36223090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study.
    Gabes M; Apfelbacher C;
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):458-463. PubMed ID: 32745352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).
    Chalmers JR; Schmitt J; Apfelbacher C; Dohil M; Eichenfield LF; Simpson EL; Singh J; Spuls P; Thomas KS; Admani S; Aoki V; Ardeleanu M; Barbarot S; Berger T; Bergman JN; Block J; Borok N; Burton T; Chamlin SL; Deckert S; DeKlotz CC; Graff LB; Hanifin JM; Hebert AA; Humphreys R; Katoh N; Kisa RM; Margolis DJ; Merhand S; Minnillo R; Mizutani H; Nankervis H; Ohya Y; Rodgers P; Schram ME; Stalder JF; Svensson A; Takaoka R; Teper A; Tom WL; von Kobyletzki L; Weisshaar E; Zelt S; Williams HC
    Br J Dermatol; 2014 Dec; 171(6):1318-25. PubMed ID: 24980543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus Statement.
    Jacobson ME; Leshem YA; Apfelbacher C; Spuls PI; Gerbens LAA; Thomas KS; Williams HC; Katoh N; Howells L; Schmitt J; Deckert S; Seshadri R; Simpson EL;
    JAMA Dermatol; 2024 Aug; 160(8):878-886. PubMed ID: 38776110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany.
    Schmitt J; Williams H;
    Br J Dermatol; 2010 Dec; 163(6):1166-8. PubMed ID: 21137114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
    Spuls PI; Gerbens LAA; Simpson E; Apfelbacher CJ; Chalmers JR; Thomas KS; Prinsen CAC; von Kobyletzki LB; Singh JA; Williams HC; Schmitt J;
    Br J Dermatol; 2017 Apr; 176(4):979-984. PubMed ID: 27858989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
    J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
    Vermeulen FM; Gerbens LAA; Bosma AL; Apfelbacher CJ; Irvine AD; Arents BWM; Barbarot S; Deleuran M; Eichenfield LF; Manca A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Middelkamp-Hup MA; Spuls PI; Flohr C;
    Br J Dermatol; 2019 Sep; 181(3):492-504. PubMed ID: 30719709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
    Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
    Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process.
    Schmitt J; Langan S; Stamm T; Williams HC;
    J Invest Dermatol; 2011 Mar; 131(3):623-30. PubMed ID: 20944653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.